Just in:
Alibaba shares slip despite 53% cloud revenue growth // Yeebo Announces Interim Results for FY26/27 Revenue Increases by 45.5% to HK$806.7 Million Profit Attributable to Owners Surges 87.6% to HK$2,284.7 Million // International Business Leaders Say Xi’s Speech Boosts Confidence in Asia-Pacific Cooperation // Jaiedco and Golden Bridge Announce Strategic Collaboration for a New Dubai Islands Development // Padmini follows Padmaja for ‘ghar vapsi’ // Sharjah clears Kalba free zone plan for 400MW complex // Anthropic shares finish above offer price after Nasdaq debut // Sui activates Hashi Bitcoin lending across partner network // Workday targets Honeydew purchase to unify AI metrics // LittleLives, Little Lab and SEGi College Sign MOU to Explore Early Childhood Education Collaboration Across ASEAN // Toward a Shared Future for Humanity: Rethinking Civilizational Exchange // Balagopal challenges CM over tax revenue // Russia permits retail cryptocurrency purchases under regulated framework // Dar Global unveils $700m Trump development in Qatar // Coinbase targets 2027 launch amid state gambling lawsuits // Oil futures rebound after Riyadh strikes and tanker alerts // PayerMax and ShopeePay Strengthen Strategic Partnership to Advance Digital Payment Collaboration in Southeast Asia // Diabetes Malaysia And Alpro Pharmacy Set National Record With 11,007 Most Blood Glucose Screenings Conducted Across Malaysia In Just 48 Hours // Thailand’s Most Iconic New Year’s Celebration Returns: ICONSIAM Unveils “Amazing Thailand Countdown 2027” // 2026 Tropical Rainforest Ecosystem Partners Conference Kicks off in Hainan //

UAE hemp law opens therapeutic pathways

Arabian Post Staff -Dubai

Federal reforms regulating industrial hemp are reshaping the treatment landscape for sleep disorders, anxiety and epilepsy across the United Arab Emirates, as clinicians, researchers and regulators map how low-THC cannabis derivatives can be used safely within a tightly controlled system. The changes sit apart from the country’s framework on medical cannabis, which governs products with higher tetrahydrocannabinol content and remains subject to strict prescription and import rules.

The hemp law permits the cultivation, processing and use of cannabis varieties containing minimal THC, typically below 0.3 per cent, aligning the UAE with regulatory models adopted in several advanced economies. Officials say the objective is to unlock therapeutic and industrial value without opening pathways to recreational misuse. For patients, the most immediate implications are for cannabidiol-based preparations, which are non-intoxicating and increasingly studied for neurological and psychiatric conditions.

The policy shift creates new clinical options for people whose symptoms have proved resistant to conventional therapies. Insomnia and generalised anxiety disorder affect a growing share of the population, while epilepsy continues to pose treatment challenges for a subset of patients who do not respond adequately to standard anti-seizure medicines. Cannabidiol, or CBD, has drawn attention for its calming effects on the central nervous system and its role in reducing seizure frequency in certain epilepsy syndromes.

Specialists caution that hemp products are not a panacea. Evidence is strongest for specific childhood epilepsies, including Dravet and Lennox-Gastaut syndromes, where purified CBD has been shown to reduce seizure burden when added to existing regimens. Research into anxiety and sleep has produced more mixed findings, though small clinical trials and observational studies suggest benefits for sleep onset and stress modulation at carefully titrated doses.

Professor Barnes, a leading authority on cannabis medicine, notes that the global legal landscape has shifted rapidly. Medical cannabis containing higher THC levels is now legal in 71 countries under varying frameworks, reflecting broader acceptance of cannabinoid-based therapies when appropriately regulated. The UAE’s approach, by contrast, draws a bright line between hemp-derived products and medical cannabis, allowing limited therapeutic use while preserving the country’s zero-tolerance stance on recreational drugs.

Regulators emphasise that access will be medicalised rather than commercialised. Hemp-derived therapeutics are expected to move through pharmacy channels and clinical oversight, with product quality, labelling and traceability forming core pillars of compliance. Authorities have indicated that cultivation licences will be tightly issued, with genetics, THC thresholds and testing protocols specified to prevent diversion.

Healthcare providers see an opportunity to expand personalised care. Neurologists and psychiatrists report rising patient interest in non-sedating options that can be integrated with existing treatments. For epilepsy specialists, CBD’s favourable side-effect profile compared with some traditional anti-epileptic drugs is a significant draw, particularly for long-term management. Sleep physicians, meanwhile, are exploring whether hemp-derived formulations can reduce reliance on hypnotics that carry dependency risks.

Industry participants are preparing cautiously. Pharmaceutical distributors and research institutions are investing in clinical studies tailored to regional populations, recognising that dosage, formulation and delivery methods matter as much as legality. Oils, capsules and oral solutions are expected to dominate, given their dosing precision and lower risk profile compared with inhaled products.

Public health experts underline the need for clear guidance to avoid consumer confusion. Hemp products sold globally range from pharmaceutical-grade medicines to wellness supplements of uneven quality. The UAE framework seeks to close that gap by requiring evidence-based claims and physician involvement, reducing the risk of self-medication or exaggerated expectations.

The reforms also intersect with broader innovation goals. By enabling controlled research into cannabinoids, policymakers aim to position the country as a regional hub for life sciences, while maintaining strict ethical standards. Universities and hospitals are already collaborating on protocols to assess safety, efficacy and long-term outcomes in local cohorts.



Notice an issue?

Arabian Post strives to deliver the most accurate and reliable information to its readers. If you believe you have identified an error or inconsistency in this article, please don't hesitate to contact our editorial team at editor[at]thearabianpost[dot]com. We are committed to promptly addressing any concerns and ensuring the highest level of journalistic integrity.


Loading next story…
Just in:
Saudi Arabia schedules multinational top-up tax for 2027 // Workday targets Honeydew purchase to unify AI metrics // Travel Insurance Was Built for the Few Who Claim. Ancileo’s Felt Coverage™ is for Everyone Else // PayerMax and ShopeePay Strengthen Strategic Partnership to Advance Digital Payment Collaboration in Southeast Asia // Coinbase targets 2027 launch amid state gambling lawsuits // Dalilk Academy reaches 27 million, targets 100 million by 2030 // Sharjah clears Kalba free zone plan for 400MW complex // Thailand’s Most Iconic New Year’s Celebration Returns: ICONSIAM Unveils “Amazing Thailand Countdown 2027” // Oil futures rebound after Riyadh strikes and tanker alerts // ED searches five districts in probe against hawala // LittleLives, Little Lab and SEGi College Sign MOU to Explore Early Childhood Education Collaboration Across ASEAN // Phancy Announces Business Performance for the Nine Months Ended September 30, 2026 // Padmini follows Padmaja for ‘ghar vapsi’ // Alibaba shares slip despite 53% cloud revenue growth // 2026 Tropical Rainforest Ecosystem Partners Conference Kicks off in Hainan // Toward a Shared Future for Humanity: Rethinking Civilizational Exchange // Balagopal challenges CM over tax revenue // Yeebo Announces Interim Results for FY26/27 Revenue Increases by 45.5% to HK$806.7 Million Profit Attributable to Owners Surges 87.6% to HK$2,284.7 Million // International Business Leaders Say Xi’s Speech Boosts Confidence in Asia-Pacific Cooperation // Jaiedco and Golden Bridge Announce Strategic Collaboration for a New Dubai Islands Development //